Low-dose Recombinant Human IL-2 for the Treatment of Relapsing Polychondritis
NCT04077736
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Relapsing Polychondritis
Interventions
DRUG:
Interleukin-2
Sponsor
Peking University People's Hospital